Menu
Search

VC in Residence

swisscanto

Age 

8 years

Team size

12

Locations

Zurich

LinkedIn
Website
Portfolio

Fund volume

CHF 500m + in AuM

Focus stage / Vertical geographic 

 Growth stage, typically Series B and C, primary focus on Switzerland

Top 3 investments 

SWISSto12
Renens-based aerospace manufacturer building advanced satellite payloads and compact geostationary spacecraft. Delivering seven HummingSat platforms for global operators; generated CHF 110M in revenue in 2025.

Ecorobotix
Yverdon-based agritech building AI-powered precision sprayers cutting chemical use by up to 95%. Over 1,000 ARA machines sold worldwide; deployed across more than 30 countries.

Schlieren-based biotech developing antibodies from human immune responses to treat severe viral infections. Lead asset potravitug completed Phase II; acquired by Ipsen in July 2026.

Managing Director

Nils Granath

Nils is a Managing Director at Swisscanto Private Equity, leading the CHF 400 million growth platform investing in technology and lifetech companies. With close to 20 years of experience in direct investments, he has served on 20+ boards and built a strong track record of launching, scaling, and exiting disruptive businesses—from start-ups to companies surpassing $200 million in revenue. Nils holds an MSc in Engineering and an MBA from INSEAD.

Watchlist

As a later-stage growth investor, we focus on the commercial scalability of technologies and the corresponding exit pathways, rather than on specific technology sub-sectors. Being part of the broader Swisscanto platform, with over CHF 300 billion in assets under management, also provides us with a significantly broader global network and information base than a typical standalone VC firm.